Dr. Abdollahi: Iran Pharma is an important pharmaceutical platform

Dr. Mohammadreza Abdollahi, CEO of Avan Bahman Chemi, stated in an interview with the Food and Drug News Agency:

This year, Avan Bahman Chemi will showcase 11 diverse products at the Iran Pharma Exhibition, all of which have been developed using the company’s R&D expertise. Among these products is the drug Telmisartan, classified under cardiovascular medicines and designed for blood pressure control, which has been produced domestically for the first time.

The Iran Pharma International Exhibition plays a vital role in expanding the market and enhancing the scientific level of Iran’s pharmaceutical industry. As one of the most important events in the country’s pharmaceutical sector, this exhibition creates numerous opportunities for interaction among manufacturers, researchers, and specialists, and provides a platform for presenting the production and technological capabilities of pharmaceutical companies.

Fortunately, this exhibition has also facilitated cooperation agreements between domestic and foreign companies and, as a key national platform, plays an important role in strengthening connections and advancing the scientific development of the country’s pharmaceutical industry.